Many patients dislike frequent insulin injections (13) and self-monitoring blood glucose, which many clinicians recommend for such intensive insulin therapy, is associated with increased scores of depression and lower quality of life scores (14,15). The gene discussed is INS; the disease is depressive symptom measurement.